Media Coverage (Selection)

April 2021

NZZ, April 17th, 2021
Die Schweizer Pharmaforschung schwächelt bei der Digitalisierung

 

STAT News / Boston Globe, April 13th, 2021

Link: Europe tries to lower drug prices with small doses of transparency

PDF: Europe tries to lower drug prices with small doses of transparency (PDF, 290 KB)

February 2021 Swissinfo, February 19th, 2021
Secret discounts leave patients at drugmakers' mercy

 

Rundschau (SRF), February 17th, 2021
Medikamentenpreise werden immer häufiger zur Geheimsache

Blackbox Medi-Preis: Geheime Pharma-Verhandlungen

January 2021

NZZ, January 19th, 2021
Künstliche Intelligenz erkennt Covid-19 am Geräusch

October 2020

New York Times, October 29th, 2020

Gilead’s Covid-19 Drug is Mediocre. It Will Be a Blockbuster Anyway

September 2020

Nature Outlook, September 23rd, 2020

Research round-up: Precision oncology

Mai 2020

Swissinfo, Mai 1st, 2020

Swiss Study Sees No Link Between Cancer Drug Prices and Patient Benefits

January 2020

Los Angeles Times, January 3rd, 2020

Artificial intelligence has come to medicine. Are patients being put at risk?

December 2019

NZZ am Sonntag, December 29th, 2019

Tödliche Lotterie für Krebskranke: Patienten müssen immer länger auf neue Medikamente warten
 

Scientific American, December 24th, 2019

Artificial intelligence is rushing into patient care—and could raise risks

 

Plädoyer, December 2nd, 2019

Interessante Schnittstelle zwischen Recht und Medizin

November 2019

Rundschau (SRF), November 20th, 2019

Teure Krebsmedikamente

September 2019

European Society for Medical Oncology, September 29th, 2019

New Studies Question Whether Novel Anti-Cancer Drugs Are Worth Their Extra Cost

 

Weltwoche, September 4th, 2019

Kopf der Woche: Kerstin Vokinger

 

Higgs, September 4th, 2019

Die Anonymisierung in Gerichtsurteilen bringt nichts

 

Forbes, September 3rd, 2019

Researchers Use Big Data And AI To Remove Legal Confidentiality

 

Tagesschau (SRF), September 2nd, 2019

So können Anonymisierungen in Gerichtsurteilen aufgehoben werden

January 2019

Business Insider, January 14th, 2019

Medicare changes could have some patients paying more for drugs

 

Channel News Asia, January 14th, 2019

Medicare changes could have some patients paying more for drugs

December 2018

Plädoyer, December 3rd, 2018

In dubio pro Krankenkasse

October 2018

PracticeUpdate, October 22nd, 2018

ESMO 2018: Highest Benefit Cancer Drugs Receive Faster Approval in European Union

 

Cancerworld, October 21st, 2018

Reimbursement of newly approved cancer drugs may take more than one year

 

Science Daily, October 19th, 2018

Securing access to optimal cancer care through innovation, integration and sustainability

 

Health Economics, October 19th, 2018

Times Vary Widely on Reimbursement Decisions for New Cancer Drugs in EU

September 2018

Tagesanzeiger, September 29th, 2018

Gewinner sind fast immer die Krankenkassen